Library Header Image
LSE Research Online LSE Library Services

Brexit and the falsified medicines directive

Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Website.

Download (43kB) | Preview


In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with the exception of requirements to verify the identity of the end-user pack, which was not due to be completed until 2019.

Item Type: Online resource (Website)
Official URL:
Additional Information: © 2017 The Author(s)
Divisions: Management
Subjects: J Political Science > JN Political institutions (Europe)
J Political Science > JN Political institutions (Europe) > JN101 Great Britain
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Date Deposited: 01 Jun 2017 10:33
Last Modified: 16 May 2024 09:04

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics